ArticleTheranostics2026

Therapeutic targeting of the AMPK-Has1 complex formation ameliorates metabolic dysfunction-associated steatohepatitis in mice.

Xunzhe Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.